NCT06562894View on ClinicalTrials.gov

Study to Evaluate Safety and Efficacy of SYHX1901 Tablets in Severe Alopecia Areata Patients

PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

156

Participants

Timeline

Start Date

May 26, 2025

Primary Completion Date

May 31, 2027

Study Completion Date

November 17, 2027

Conditions
Severe Alopecia Areata
Interventions
DRUG

SYHX1901

Administered orally, once daily (QD)

DRUG

Placebo

Administered orally, once daily (QD)

Sponsors
All Listed Sponsors
collaborator

CSPC ZhongQi Pharmaceutical Technology Co., Ltd.

INDUSTRY

lead

CSPC Ouyi Pharmaceutical Co., Ltd.

INDUSTRY

NCT06562894 - Study to Evaluate Safety and Efficacy of SYHX1901 Tablets in Severe Alopecia Areata Patients | Biotech Hunter | Biotech Hunter